Dr. Staelin's 8/10 BIEL Investor Letter Revisited
Post# of 7796
(Total Views: 359)
Posted On: 02/26/2021 3:51:16 PM
Dr. Staelin's 8/10 BIEL Investor Letter Revisited
Took another read of this letter for perspective with today's status. Based on this paragraph and DD I don't believe SAI is BIEL's third US OEM OTC Partner mentioned in the Letter. IMO, Partner #3 is still to be announced.
"1. We now have signed long term contracts with, and received initial stocking orders and cash deposits from, three major companies. These initial orders total more than 120,000 ActiPatch devices. These three companies will be selling our devices into the United States over-the-counter (OTC) consumer health retail market. They will differentiate their offerings by utilizing different retail channels, branding strategies, and attachment systems (to affix the device on to various locations on the body). Their retail launch dates vary but are currently scheduled between Q4 of 2020 and Q2 of 2021, reflecting industry practice for retailers to plan launch times six to nine months into the future."
Partners One & Two match with Staelin's description but SAI is marketing in both the US and Canada not just the US as the Letter states.
DJO Launched in 11/2020, Q4 Partner.
KT Tape Launched in February 2021, Q1 2021 Partner (they were outted as a Partner in December when their FDA Registration was published).
SAI was a similar situation to KT with the FDA Registration disclosing the Partnership but word on the street is they plan to Launch in March, Q1 2021.
SAI products line up with DJO's as far as using a Wrap to affix the device.
I feel we see OEM Partner #3 from the Letter emerge in Q2 2021 and SAI is a bonus Partner that came later.
https://finance.yahoo.com/news/bioelectronics...00462.html
Took another read of this letter for perspective with today's status. Based on this paragraph and DD I don't believe SAI is BIEL's third US OEM OTC Partner mentioned in the Letter. IMO, Partner #3 is still to be announced.
"1. We now have signed long term contracts with, and received initial stocking orders and cash deposits from, three major companies. These initial orders total more than 120,000 ActiPatch devices. These three companies will be selling our devices into the United States over-the-counter (OTC) consumer health retail market. They will differentiate their offerings by utilizing different retail channels, branding strategies, and attachment systems (to affix the device on to various locations on the body). Their retail launch dates vary but are currently scheduled between Q4 of 2020 and Q2 of 2021, reflecting industry practice for retailers to plan launch times six to nine months into the future."
Partners One & Two match with Staelin's description but SAI is marketing in both the US and Canada not just the US as the Letter states.
DJO Launched in 11/2020, Q4 Partner.
KT Tape Launched in February 2021, Q1 2021 Partner (they were outted as a Partner in December when their FDA Registration was published).
SAI was a similar situation to KT with the FDA Registration disclosing the Partnership but word on the street is they plan to Launch in March, Q1 2021.
SAI products line up with DJO's as far as using a Wrap to affix the device.
I feel we see OEM Partner #3 from the Letter emerge in Q2 2021 and SAI is a bonus Partner that came later.
https://finance.yahoo.com/news/bioelectronics...00462.html
(2)
(1)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼